Money

Merck snags Chinese obesity drug in nearly $2 billion deal



Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. Read More


Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *